Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill

Rhea-AI Summary

Co-Diagnostics (CODX) announced its participation at BioUtah's Life Sciences Day on the Hill at the Utah State Capitol Rotunda on January 30, 2025. The event, presented by the Utah Life Sciences Innovation Caucus, the Utah Governor's Office of Economic Opportunity, and BioUtah, features over 25 Utah life sciences companies.

At the event, Co-Dx will showcase its upcoming Co-Dx PCR testing platform for at-home and point-of-care detection of infectious diseases, including COVID-19, influenza, RSV, HPV, and tuberculosis. The platform features cloud-based analysis capabilities for tracking disease outbreaks and is operated through a smartphone interface.

The company notes that the Co-Dx PCR platform, including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and associated tests and software, is currently under FDA review and not yet available for sale.

News Market Reaction

-0.21%

1 alert

-0.21% News Effect

On the day this news was published, CODX declined 0.21%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced that it will be hosting a booth at BioUtah's Life Sciences Day on the Hill today at the Utah State Capitol Rotunda.

The Life Sciences Day on the Hill is presented by the Utah Life Sciences Innovation Caucus, the Utah Governor's Office of Economic Opportunity, and BioUtah, an independent trade association serving the life sciences community in Utah. BioUtah is comprised of manufacturers and developers of medical devices, pharmaceuticals, diagnostics and biotechnology products as well as government, academic and health care institutions all focused on improving health and wellness through the delivery of innovative technologies and services.

The event follows the Company's participation with the Utah Governor's Office of Economic Opportunity on the World Trade Center Utah's trade mission to Asia last fall, and continues Co-Dx's outreach to strengthen global and local relationships.

This year's event takes place today, January 30, from 11:00 AM to 2:00 PM MST, and is expected to feature exhibits from over 25 Utah life sciences companies. Co-Dx's booth will showcase the Company's upcoming at-home and point-of care Co-Dx PCR testing platform* for detection of infectious diseases, including COVID-19, influenza, RSV, HPV and tuberculosis. The platform also incorporates cloud-based analysis to help build situational awareness and provide support to track infectious disease outbreaks at the community and regional level, all operated via an intuitive smartphone interface.

*The Co-Dx PCR platform (including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and all associated tests and software) is subject to review by the FDA and/or other regulatory bodies and is not available for sale. The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are currently under review by the FDA.

About Co-Diagnostics, Inc.:
Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform and to locate genetic markers for use in applications other than infectious disease.

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-to-exhibit-at-bioutahs-2025-life-sciences-day-on-the-hill-302364228.html

SOURCE Co-Diagnostics

FAQ

What products will Co-Diagnostics (CODX) showcase at BioUtah's 2025 Life Sciences Day?

Co-Diagnostics will showcase its upcoming Co-Dx PCR testing platform for at-home and point-of-care detection of infectious diseases, including COVID-19, influenza, RSV, HPV, and tuberculosis, featuring cloud-based analysis and smartphone interface.

What is the regulatory status of CODX's new PCR testing platform?

The Co-Dx PCR platform, including the Co-Dx PCR Home™, Co-Dx PCR Pro™, mobile app, and associated tests and software, is currently under FDA review and not available for sale.

When and where is BioUtah's 2025 Life Sciences Day taking place?

BioUtah's Life Sciences Day is taking place on January 30, 2025, from 11:00 AM to 2:00 PM MST at the Utah State Capitol Rotunda.

What diseases can CODX's new PCR platform detect?

The platform is designed to detect multiple infectious diseases including COVID-19, influenza, RSV, HPV, and tuberculosis.